Willowbrooke Court At Country House in Wilmington, DE

Willowbrooke Court At Country House is a medicare certified nursing home in Wilmington, Delaware. It is located in New Castle county at 4830 Kennett Pike, Wilmington, Delaware 19807. You can reach out to the office of Willowbrooke Court At Country House via phone at (302) 654-5101. This skilled nursing facility has 60 federally certified beds with average occupancy rate of 15.17%. The nursing facility is classified as "Continuing Care Retirement Community" by CMS and its legal business name is Acts Retirement-life Communities Inc and has the following ownership type - Non Profit - Corporation.

Willowbrooke Court At Country House (Medicare CCN 085003) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in medicare program. This means if you are part of medicare program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1967 (57 years certified) and the last quality survey was conducted in July, 2019.

Contact Information

Willowbrooke Court At Country House
4830 Kennett Pike, Wilmington, Delaware 19807
(302) 654-5101


Nursing Home Profile

NameWillowbrooke Court At Country House
Location4830 Kennett Pike, Wilmington, Delaware
Certified ByMedicare
No. of Certified Beds60
Occupancy Rate15.17%
Medicare ID (CCN)085003
Legal Business NameActs Retirement-life Communities Inc
Ownership TypeNon Profit - Corporation

NPI Associated with this Nursing Home:

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Willowbrooke Court At Country House from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1548265770
Organization NameACTS RETIREMENT-LIFE COMMUNITIES, INC.
Doing Business AsWILLOWBROOKE COURT AT COUNTRY HOUSE
Address4830 Kennett Pike, Wilmington, DE 19807
Phone Number302-654-5101

News Archive

Inspire fourth quarter revenues increase 2% to $30.3 million

Inspire Pharmaceuticals, announced today financial results for the fourth quarter and year ended December 31, 2010. For the quarter ended December 31, 2010, the Company reported a net loss of $4.3 million, or per common share, compared to a net loss of $2.6 million, or per common share, for the same period in 2009.

Alexza Pharmaceuticals licenses Staccato nicotine technology to Cypress Bioscience

Alexza Pharmaceuticals, Inc. announced today that it has licensed its Staccato nicotine technology to Cypress Bioscience, Inc. The Staccato nicotine technology is a novel electronic multidose delivery system designed to help people stop smoking. The Staccato nicotine technology is intended to improve on a well-validated smoking cessation approach by delivering nicotine via inhalation, mimicking the nicotine effects of smoking without the harmful side effects associated with cigarettes.

First Edition: March 30, 2012

Today's health policy headlines include reports that the House yesterday approved the $3.5 trillion budget plan proposed by Paul Ryan - which includes deep cuts in entitlements and will likely trigger the election-year fiscal debate.

As COVID testing soars, wait times for results jump to a week — or more

Elliot Truslow went to a CVS drugstore on June 15 in Tucson, Arizona, to get tested for the coronavirus. The drive-thru nasal swab test took less than 15 minutes.

AIDS mortality in China drops by nearly two thirds since 2002 when country began free treatment program

China's HIV/AIDS-related mortality has dropped from 39.3 per 100 person-years in 2002 to 14.2 in 2009, or 64 percent, since the nation began providing free antiretroviral therapy (ART) in 2002, according to a study conducted by researchers from the Chinese Center for Disease Control and Prevention and published online Wednesday in Lancet Infectious Diseases, the New York Times reports (McNeil, 5/18).

Read more Medical News

› Verified 8 days ago

Quality Ratings:

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Willowbrooke Court At Country House are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Willowbrooke Court At Country House give to their patients.
Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Inspire fourth quarter revenues increase 2% to $30.3 million

Inspire Pharmaceuticals, announced today financial results for the fourth quarter and year ended December 31, 2010. For the quarter ended December 31, 2010, the Company reported a net loss of $4.3 million, or per common share, compared to a net loss of $2.6 million, or per common share, for the same period in 2009.

Alexza Pharmaceuticals licenses Staccato nicotine technology to Cypress Bioscience

Alexza Pharmaceuticals, Inc. announced today that it has licensed its Staccato nicotine technology to Cypress Bioscience, Inc. The Staccato nicotine technology is a novel electronic multidose delivery system designed to help people stop smoking. The Staccato nicotine technology is intended to improve on a well-validated smoking cessation approach by delivering nicotine via inhalation, mimicking the nicotine effects of smoking without the harmful side effects associated with cigarettes.

First Edition: March 30, 2012

Today's health policy headlines include reports that the House yesterday approved the $3.5 trillion budget plan proposed by Paul Ryan - which includes deep cuts in entitlements and will likely trigger the election-year fiscal debate.

As COVID testing soars, wait times for results jump to a week — or more

Elliot Truslow went to a CVS drugstore on June 15 in Tucson, Arizona, to get tested for the coronavirus. The drive-thru nasal swab test took less than 15 minutes.

AIDS mortality in China drops by nearly two thirds since 2002 when country began free treatment program

China's HIV/AIDS-related mortality has dropped from 39.3 per 100 person-years in 2002 to 14.2 in 2009, or 64 percent, since the nation began providing free antiretroviral therapy (ART) in 2002, according to a study conducted by researchers from the Chinese Center for Disease Control and Prevention and published online Wednesday in Lancet Infectious Diseases, the New York Times reports (McNeil, 5/18).

Read more Medical News

› Verified 8 days ago

Complaints, Fines and Penalties:

Number of Facility Reported Incidents0
Number of Substantiated Complaints0
Number of Fines0
Total Amount of Fines in Dollars$0
Number of Payment Denials0
Total Number of Penalties0

Patients' Stay Experience:

The resident survey data of Willowbrooke Court At Country House is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience MeasureProviderNational Avg.